- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | AtaCor raises $75M to support extravascular defibrillator | ||
| Mo | The top surgical robotics stories of 2025 so far | ||
| Mo | Gore, Olympus ink distro deal for Viabil endoprosthesis | ||
| Mo | Olympus launches single-use needle biopsy device | ||
| Mo | Panda Surgical raises $1.3M for handheld neurosurgical robot | ||
| Fr | FDA approves IceCure cryoablation for breast cancer | ||
| Fr | FDA clears pivotal trial for AorticLab's FLOWer embolic protection system | ||
| Fr | Elixir Medical announces full LithiX IVL rollout in Europe | ||
| Fr | The top BCI stories of 2025 so far | ||
| Fr | Plexaa launches Bloom43 wearable breast surgery prep device | ||
| 02.10. | Philips, Getinge partner on anesthesia monitoring | ||
| 02.10. | SS Innovations is set to submit its surgical robot to the FDA | ||
| 02.10. | DermaSensor raises $16M Series B to support skin cancer detection device | ||
| 02.10. | J&J MedTech's orthopedics head joins Dentsply Sirona as CCO | ||
| 02.10. | Court sides with Medtronic in insulin pump class action suit | ||
| 02.10. | EndoQuest Robotics reports first gastroenterologist case in endoluminal robot trial | ||
| 02.10. | Siemens Healthineers is reportedly being considered for a spinoff | ||
| 02.10. | ClearPoint Neuro is developing a robotic neuro-navigation system for drug delivery | ||
| 02.10. | Precision Neuroscience study backs minimally invasive BCI | ||
| 01.10. | Medtronic wins CE mark for left atrial appendage exclusion system | ||
| 01.10. | 4 breast cancer technology advances to know | ||
| 01.10. | Cognixion launches study pairing BCI with Apple Vision Pro without surgery | ||
| 01.10. | Smith+Nephew launches pre-op planning, modeling services for total shoulder arthroplasty | ||
| 01.10. | Former Abiomed CEO to run for Governor of Massachusetts | ||
| 01.10. | Adagio completes enrollment in ultra-low temp cryoablation trial |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .